Adult T-Cell Leukemia/Lymphoma — Trials

Adult T-Cell Leukemia/Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

121 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: Carlos Brites
Termination share: 28.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00060112	Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma	terminated	Phase 1	15	National Cancer Institute (NCI)NIH	1	Jan 25, 2013	clinicaltrials
NCT00089271	17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas	completed	Phase 1	60	National Cancer Institute (NCI)NIH	1	Jan 25, 2013	clinicaltrials